Position in JANX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,083,020
+$1,748,783 QoQ
Shares Held
221,800
+129.4% QoQ
Ownership
0.364%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jump Financial, LLC holds $252,934,314 across 133 Biotechnology names. JANX ranks #24 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
206,675 | $15,519,225 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
291,488 | $11,726,562 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
507,828 | $11,050,335 | |
| 4 | DAWN |
Day One Biopharmaceuticals, Inc.
|
497,365 | $10,663,505 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
504,143 | $10,561,795 | |
| 6 | LEGN |
Legend Biotech Corp
|
516,633 | $9,345,890 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
155,776 | $9,058,374 | |
| 8 | BNTX |
BioNTech SE
|
79,189 | $7,038,317 |
All Filings in JANX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,083,020 | 221,800 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,334,237 | 96,684 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,391,868 | 179,700 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,276,733 | 228,430 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,538,810 | 94,030 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $758,209 | 18,100 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $590,765 | 15,691 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $128,444 | 10,821 | Shares | Sole | 2023-08-07 | |
| No filing history on record for this holder in this stock. | ||||||